From: John W. Jayne, M.D. [j.jaynemd@worldnet.att.net] Sent: Monday, April 30, 2001 3:52 AM To: Titus, Sandra L Subject: Changing Long-acting Antihistamines to OTC Dear Madams/Sirs: I have recently been informed that the FDA is considering changing the newer long-acting antihistamines to OTC. The great majority of patients do not consider OTC "medications" to be medications at all! This is a problem! These newer antihistamines (Allegra, Zyrtec and Claritin) are very effective medications with long half-lives. They affect all forms of atopy, not only seasonal allergies. If these medications were to become available without a prescription, then assessment of the patient would be much more difficult because they do affect clinical evaluation, skin testing, and even bronchial provocations! Furthermore, follow-up assessments and treatment would also be more difficult because there would not be any method to assess compliance! I would like to briefly discuss the differences between what might be considered "fair" and "right." Is it "fair" for the pharmaceutical industry to loose money so that the insurance industry can save money? Is it "fair" to the patients for the pharmaceutical companies to decrease R & D resources, particularly in those areas where there may be only a limited group of patients who may benefit, because of those fears? The pharmaceutical industry has always supported patients, research for the betterment of mankind, education for patients and their families, physicians, education for physicians and even has supported the FDA! The FDA is one of the most respected (if not the most respected) institutions in the U.S. today! I personally have had very limited exposure to the FDA, however, I must state that my experiences have been unbelievably positive! I will never forget that 17 years ago I needed something that only the FDA could give for a young man who was dying! Though I had a hard time reaching the correct department, once I did, I was helped and a favorable decision was made within 10 minutes! Now, if I may relay that which I believe is "right." That is, that which is in the best interest of the patient! This is an issue, which I am sure is in agreement with the desires of the FDA! It is not in the best interest of the patient to have more uncontrolled OTC medications that can (and will) be taken incorrectly, abusively, or non-compliantly! Who is to take responsibility? The patient? The pharmaceutical industry who invented the medication? The physician? Or the FDA? Certainly not the Insurance Company! Remember, the pharmaceutical companies and the physicians are friends to the FDA, just as the FDA is a friend to both the physicians and the pharmaceutical industry! Why? Because we all three share a common goal and bond: the health and well-being of the patient! I truly appreciate your time in this very important matter. I am . . . Very truly yours, John W. Jayne, M.D.